Page last updated: 2024-09-05

schaftoside and Non-alcoholic Fatty Liver Disease

schaftoside has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cai, W; Liu, C; Liu, M; Mi, S; Song, M; Wang, J; Wu, S; Zhang, G1

Other Studies

1 other study(ies) available for schaftoside and Non-alcoholic Fatty Liver Disease

ArticleYear
Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
    Journal of ethnopharmacology, 2020, Jun-12, Volume: 255

    Topics: Animals; Cell Line, Tumor; Cholesterol; Diet, High-Fat; Disease Models, Animal; Glycosides; Hepatocytes; Humans; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Triglycerides; Up-Regulation

2020